Michael A. Fortunato - 09 Aug 2026 Form 4 Insider Report for BioStem Technologies, Inc. (BSEM)

Reporting relationship
Chief Accounting Officer
Issuer ticker
BSEM
Reported as of
09 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 19:30:04 UTC
Prior SEC filing
14 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Katherine Gorrell, Attorney-in-Fact

Key filing fact

Michael A. Fortunato filed Form 4 for BioStem Technologies, Inc. (BSEM) on 20 Aug 2026.

Key facts

  • This page summarizes Michael A. Fortunato's Form 4 filing for BioStem Technologies, Inc. (BSEM).
  • 2 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2026, 19:30.

Change

  • Previous filing in this sequence was filed on 14 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147232 Primary reporting owner

FORTUNATO MICHAEL A

Relationship
Chief Accounting Officer
Address
C/O BIOSTEM TECHNOLOGIES, INC., 2836 CENTER PORT CIRCLE, POMPANO BEACH
Signature
/s/ Katherine Gorrell, Attorney-in-Fact
Signature date
20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSEM transaction

Common Stock

Options Exercise

Transaction value
Shares
+970
Change %
+1.5%
Price
$0.000000*
Shares after
64,430
Date
09 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSEM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-970
Change %
-12%
Price
$0.000000*
Shares after
6,790
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
970
Exercise price
Footnotes
F6, F8
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
200,000
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$1.07
Footnotes
F1
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100,000
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$2.99
Footnotes
F2
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,582
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,582
Exercise price
$15.11
Footnotes
F3
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,340
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,340
Exercise price
$15.11
Footnotes
F4
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,546
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
38,546
Exercise price
$5.50
Footnotes
F5
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,175
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,175
Exercise price
Footnotes
F6, F7
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,818
Date
09 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,818
Exercise price
Footnotes
F6, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

These options are fully vested and exercisable.

Footnote F2

These options vest according to the following schedule: 25% vested on January 4, 2024, with the remaining options vesting in equal monthly installments over the subsequent three year period.

Footnote F3

These options vest with the following schedule: 33% vested on May 9, 2026, with the remaining options vesting in equal quarterly installment over the subsequent two year period.

Footnote F4

These option vest with the following schedule: 33% will vest on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F5

These options vest with the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F6

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F7

These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Footnote F8

These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business day of the applicable transaction date.

Footnote F9

These restricted stock units vest according to the following schedule: 33% vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .